Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks advance as investors shrug off weak data

Thu, 21st Aug 2014 12:01

- Mining stocks fall as Chinese data weakens- Eurozone PMIs and UK retail sales disappoint- US data, Jackson Hole aheadtechMARK 2,810.76 +0.50%FTSE 100 6,772.04 +0.25%FTSE 250 15,797.15 +0.31%Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursday despite a barrage of weak economic data from across the globe."The data seen so far today hasn't been great but that hasn't affected investors' appetite for risk, as European indices have continued their march higher," said market analyst Craig Erlam from Alpari UK.London's Footsie was trading 0.25% higher at 6,772 by midday.Economic data misses forecastsMining stocks were under pressure in morning trade after manufacturing data from top metals consumer China disappointed, while metals prices weakened on the back of a stronger US dollar.The HSBC China manufacturing purchasing managers' index (PMI) dropped from 51.7 to a three-month low 50.3 in August. The fall ended a streak of four straight monthly improvements in activity growth and disappointed analysts looking for a slight dip to 51.5.The Eurozone composite PMI, which measures activity in both manufacturing and services, fell from 53.8 to 52.8 in August, missing the 53.4 forecast as readings from both sectors came in below expectations.Closer to home, UK retail sales growth came in at just 0.1% in July, under the 0.4% increase expected by analysts, according to Office for National Statistics. The ONS also released figures showing that while UK public finances improved last month borrowing still remains above the government's target.Looking ahead to the US session, stock futures on Wall Street were edging higher in pre-market trade ahead of a host of economic data, including jobless claims, the Markit manufacturing PMI, existing-home sales and the Philadelphia Fed index.Meanwhile, the Jackson Hole Symposium of central bankers is due to kick off later on with comments from policymakers around the world likely to be closely watched.Mining stocks fallWeak data from top metals consumer China and falling metal prices dampened the demand for mining stocks on Wednesday with Fresnillo, Randgold, Rio Tinto, Anglo American and BHP Billiton trading lower.BHP Billiton was still under pressure in the aftermath of Tuesday's underwhelming plans for a demerger. Chief financial officer Graham Kerr, who is due to be the head of the spin-off company, has been cited as saying that the lack of a share buyback - which many investors had been expecting - was a "sore point", while plans to give shareholders stock in the new firm could have "irritated" some who are not mandated to hold investments in Australia. Kazakh metal miner Kazakhmys hailed progress with a shake-up designed to focus it on the lucrative copper market, but shares fell sharply after it said 2014 gold production was likely to fall short of hopes.Oil and gas stocks were also out of favour including Ophir Energy, Tullow and Shell.Premier Oil was more or less flat after saying it had a "strong six months" with better-than-expected production leading to higher revenues and cash flows. However, it saw a sharp reduction in pre-tax profit in the first half due to impairments.Leading the upside in London were a raft of pharmaceutical and biotechnology stocks, including Astrazeneca, Glaxosmithkline, Shire and Hikma Pharmaceuticals.Financials such as Schroders, Aviva, Old Mutual and Hargreaves Lansdown were also providing a lift.FTSE 100 - RisersSchroders (SDR) 2,385.00p +2.36%AstraZeneca (AZN) 4,372.50p +2.04%GlaxoSmithKline (GSK) 1,438.00p +1.45%CRH (CRH) 1,391.00p +1.31%Ashtead Group (AHT) 945.50p +1.23%Old Mutual (OML) 196.20p +1.13%Barratt Developments (BDEV) 363.50p +1.08%Aviva (AV.) 521.00p +1.07%Diageo (DGE) 1,769.00p +1.00%Hargreaves Lansdown (HL.) 1,120.00p +0.99%FTSE 100 - FallersFresnillo (FRES) 938.50p -3.50%Kingfisher (KGF) 306.60p -1.73%Anglo American (AAL) 1,576.50p -1.10%Randgold Resources Ltd. (RRS) 4,947.00p -1.00%Royal Mail (RMG) 441.80p -0.88%Antofagasta (ANTO) 812.00p -0.85%Rio Tinto (RIO) 3,430.00p -0.81%Standard Chartered (STAN) 1,211.50p -0.78%Pearson (PSON) 1,120.00p -0.71%easyJet (EZJ) 1,330.00p -0.67%FTSE 250 - RisersRank Group (RNK) 166.00p +3.49%Imagination Technologies Group (IMG) 204.90p +3.48%Hikma Pharmaceuticals (HIK) 1,740.00p +2.84%Domino Printing Sciences (DNO) 647.00p +2.70%International Personal Finance (IPF) 519.00p +2.57%Amlin (AML) 439.00p +2.26%Fisher (James) & Sons (FSJ) 1,366.00p +2.25%Euromoney Institutional Investor (ERM) 1,073.00p +2.19%Senior (SNR) 287.70p +2.17%Xaar (XAR) 558.50p +2.10%FTSE 250 - FallersKazakhmys (KAZ) 292.90p -5.06%Thomas Cook Group (TCG) 119.80p -3.39%Just Retirement Group (JRG) 145.30p -3.20%Hochschild Mining (HOC) 162.20p -2.29%Centamin (DI) (CEY) 62.85p -2.26%Petra Diamonds Ltd.(DI) (PDL) 186.80p -2.05%Ophir Energy (OPHR) 225.20p -1.96%African Barrick Gold (ABG) 240.30p -1.52%Serco Group (SRP) 305.10p -1.39%Stock Spirits Group (STCK) 290.50p -1.36%BC
More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.